We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$205M
AUM Growth
-$5.12M
Cap. Flow
-$18.3M
Cap. Flow %
-8.92%
Top 10 Hldgs %
57.35%
Holding
100
New
11
Increased
17
Reduced
52
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXC icon
51
Exelon
EXC
$47B
$408K 0.2%
9,431
-929
-9% -$36.7K
JPST icon
52
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$407K 0.2%
8,083
-455
-5% -$22.8K
MPC icon
53
Marathon Petroleum
MPC
$83.7B
$406K 0.2%
3,488
-1,237
-26% -$141K
MCK icon
54
McKesson
MCK
$101B
$397K 0.19%
1,059
-294
-22% -$110K
CNP icon
55
CenterPoint Energy
CNP
$26.8B
$385K 0.19%
12,825
-2,712
-17% -$78.9K
UNH icon
56
UnitedHealth
UNH
$370B
$381K 0.19%
+719
New +$381K
ENPH icon
57
Enphase Energy
ENPH
$5.53B
$341K 0.17%
+1,286
New +$374K
BXSL icon
58
Blackstone Secured Lending
BXSL
$5.72B
$331K 0.16%
14,135
REZ icon
59
iShares Residential and Multisector Real Estate ETF
REZ
$879M
$282K 0.14%
+3,882
New +$272K
AAPL icon
60
Apple
AAPL
$4.57T
$277K 0.14%
1,961
-58
-3% -$8.29K
MOS icon
61
The Mosaic Company
MOS
$7.33B
$273K 0.13%
78,465
+70,053
+833% +$3.47M
FVD icon
62
First Trust Value Line Dividend Fund
FVD
$8.41B
$244K 0.12%
6,030
RDVY icon
63
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
$233K 0.11%
+5,000
New +$219K
FSK icon
64
FS KKR Capital
FSK
$3.44B
$222K 0.11%
11,501
MRK icon
65
Merck
MRK
$318B
$178K 0.09%
1,605
-2,310
-59% -$236K
ABBV icon
66
AbbVie
ABBV
$435B
$174K 0.09%
1,076
-879
-45% -$135K
REGN icon
67
Regeneron Pharmaceuticals
REGN
$80.8B
$165K 0.08%
228
-229
-50% -$169K
MRNA icon
68
Moderna
MRNA
$23.6B
$163K 0.08%
910
-863
-49% -$141K
VRTX icon
69
Vertex Pharmaceuticals
VRTX
$126B
$154K 0.08%
532
-711
-57% -$217K
BNTX icon
70
BioNTech
BNTX
$23.5B
$151K 0.07%
1,004
-819
-45% -$126K
A icon
71
Agilent Technologies
A
$41.2B
$119K 0.06%
+797
New +$114K
HZNP
72
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$80.2K 0.04%
705
-1,242
-64% -$103K
LH icon
73
Labcorp
LH
$25.9B
$61.2K 0.03%
303
-700
-70% -$137K
INCY icon
74
Incyte
INCY
$24.4B
$59K 0.03%
734
-1,242
-63% -$95K
CPRX
75
DELISTED
Catalyst Pharmaceutical
CPRX
$40.1K 0.02%
2,158
-1,920
-47% -$29.6K

Similar funds

Anfield Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Anfield Capital Management held 100 positions worth $205M, down 2.4% from $210M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Anfield Capital Management withdrew a net $18.3M in Q4 2022, closing 15 positions and reducing 52 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $2.52M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 1.8% of assets, up from 1.8% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Anfield Capital Management opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $6.43M.

  • Anfield Capital Management's largest Q4 2022 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 99,578 shares worth $6.43M.
  • Anfield Capital Management added most to Anfield US Equity Sector Rotation ETF in Q4 2022, an estimated $8.71M increase.
  • Anfield Capital Management's biggest Q4 2022 reduction was Anfield Diversified Alternatives ETF, cutting an estimated $8.13M.
  • Anfield Capital Management fully exited State Street Materials Select Sector SPDR ETF in Q4 2022, selling an estimated $2.52M.
  • Anfield Capital Management's ten largest holdings make up 57% of its $205M portfolio in Q4 2022.
  • Anfield Capital Management opened 11 new positions and closed 15 in Q4 2022.
  • Anfield Capital Management's portfolio value fell 2.4% quarter-over-quarter to $205M.

Based on Anfield Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.